DERMAPHARM HOLDING SE (DMP.DE) Stock Fundamental Analysis
Europe - FRA:DMP - DE000A2GS5D8 - Common Stock
32.525 EUR
-0.02 (-0.08%)
Taking everything into account, DMP scores 5 out of 10 in our fundamental rating. DMP was compared to 50 industry peers in the Pharmaceuticals industry. There are concerns on the financial health of DMP while its profitability can be described as average. DMP is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year DMP was profitable.
In the past year DMP had a positive cash flow from operations.
In the past 5 years DMP has always been profitable.
In the past 5 years DMP always reported a positive cash flow from operatings.
1.2 Ratios
DMP has a Return On Assets (5.02%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 17.62%, DMP is in the better half of the industry, outperforming 62.00% of the companies in the same industry.
With a Return On Invested Capital value of 7.50%, DMP perfoms like the industry average, outperforming 46.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for DMP is significantly below the industry average of 15.33%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.02% | ||
| ROE | 17.62% | ||
| ROIC | 7.5% |
ROA(3y)5.95%
ROA(5y)7.95%
ROE(3y)18.55%
ROE(5y)24.89%
ROIC(3y)9.78%
ROIC(5y)10.35%
1.3 Margins
DMP's Profit Margin of 9.11% is in line compared to the rest of the industry. DMP outperforms 44.00% of its industry peers.
DMP's Profit Margin has declined in the last couple of years.
DMP has a Operating Margin of 18.55%. This is comparable to the rest of the industry: DMP outperforms 52.00% of its industry peers.
In the last couple of years the Operating Margin of DMP has grown nicely.
DMP has a worse Gross Margin (65.67%) than 60.00% of its industry peers.
DMP's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.55% | ||
| PM (TTM) | 9.11% | ||
| GM | 65.67% |
OM growth 3Y-14.93%
OM growth 5Y2.07%
PM growth 3Y-24.31%
PM growth 5Y-2.64%
GM growth 3Y-0.44%
GM growth 5Y3.48%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so DMP is still creating some value.
The number of shares outstanding for DMP remains at a similar level compared to 1 year ago.
The number of shares outstanding for DMP remains at a similar level compared to 5 years ago.
Compared to 1 year ago, DMP has a worse debt to assets ratio.
2.2 Solvency
DMP has an Altman-Z score of 2.04. This is not the best score and indicates that DMP is in the grey zone with still only limited risk for bankruptcy at the moment.
DMP's Altman-Z score of 2.04 is on the low side compared to the rest of the industry. DMP is outperformed by 60.00% of its industry peers.
DMP has a debt to FCF ratio of 5.76. This is a neutral value as DMP would need 5.76 years to pay back of all of its debts.
DMP has a Debt to FCF ratio of 5.76. This is comparable to the rest of the industry: DMP outperforms 46.00% of its industry peers.
DMP has a Debt/Equity ratio of 1.52. This is a high value indicating a heavy dependency on external financing.
DMP has a worse Debt to Equity ratio (1.52) than 74.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.52 | ||
| Debt/FCF | 5.76 | ||
| Altman-Z | 2.04 |
ROIC/WACC1.24
WACC6.06%
2.3 Liquidity
A Current Ratio of 1.84 indicates that DMP should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.84, DMP is in the better half of the industry, outperforming 70.00% of the companies in the same industry.
A Quick Ratio of 0.87 indicates that DMP may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.87, DMP is in line with its industry, outperforming 44.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.84 | ||
| Quick Ratio | 0.87 |
3. Growth
3.1 Past
DMP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.17%, which is quite impressive.
The Earnings Per Share has been growing by 8.07% on average over the past years. This is quite good.
Looking at the last year, DMP shows a small growth in Revenue. The Revenue has grown by 3.98% in the last year.
The Revenue has been growing by 11.00% on average over the past years. This is quite good.
EPS 1Y (TTM)29.17%
EPS 3Y-18.42%
EPS 5Y8.07%
EPS Q2Q%21.61%
Revenue 1Y (TTM)3.98%
Revenue growth 3Y7.79%
Revenue growth 5Y11%
Sales Q2Q%-2.74%
3.2 Future
Based on estimates for the next years, DMP will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.22% on average per year.
DMP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.79% yearly.
EPS Next Y13.74%
EPS Next 2Y12.47%
EPS Next 3Y11.86%
EPS Next 5Y14.22%
Revenue Next Year-0.58%
Revenue Next 2Y1.65%
Revenue Next 3Y2.36%
Revenue Next 5Y2.79%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 16.34 indicates a correct valuation of DMP.
The rest of the industry has a similar Price/Earnings ratio as DMP.
DMP is valuated rather cheaply when we compare the Price/Earnings ratio to 27.41, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 12.57, DMP is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DMP indicates a somewhat cheap valuation: DMP is cheaper than 68.00% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of DMP to the average of the S&P500 Index (22.87), we can say DMP is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.34 | ||
| Fwd PE | 12.57 |
4.2 Price Multiples
DMP's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. DMP is cheaper than 74.00% of the companies in the same industry.
DMP's Price/Free Cash Flow ratio is rather cheap when compared to the industry. DMP is cheaper than 88.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.98 | ||
| EV/EBITDA | 8.55 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.19
PEG (5Y)2.03
EPS Next 2Y12.47%
EPS Next 3Y11.86%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.75%, DMP has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.07, DMP pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, DMP has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.75% |
5.2 History
The dividend of DMP has a limited annual growth rate of 2.71%.
Dividend Growth(5Y)2.71%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
44.20% of the earnings are spent on dividend by DMP. This is a bit on the high side, but may be sustainable.
DMP's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP44.2%
EPS Next 2Y12.47%
EPS Next 3Y11.86%
FRA:DMP (9/23/2025, 11:46:38 AM)
32.525
-0.02 (-0.08%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners14.73%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.75B
Analysts78.18
Price Target43.25 (32.97%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.75% |
Yearly Dividend0.88
Dividend Growth(5Y)2.71%
DP44.2%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.61%
PT rev (3m)-6.61%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-0.72%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1%
Revenue NY rev (3m)-1.16%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.34 | ||
| Fwd PE | 12.57 | ||
| P/S | 1.49 | ||
| P/FCF | 9.98 | ||
| P/OCF | 8.12 | ||
| P/B | 2.88 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.55 |
EPS(TTM)1.99
EY6.12%
EPS(NY)2.59
Fwd EY7.95%
FCF(TTM)3.26
FCFY10.02%
OCF(TTM)4
OCFY12.31%
SpS21.86
BVpS11.3
TBVpS-8.64
PEG (NY)1.19
PEG (5Y)2.03
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.02% | ||
| ROE | 17.62% | ||
| ROCE | 12.3% | ||
| ROIC | 7.5% | ||
| ROICexc | 8.28% | ||
| ROICexgc | 24.86% | ||
| OM | 18.55% | ||
| PM (TTM) | 9.11% | ||
| GM | 65.67% | ||
| FCFM | 14.9% |
ROA(3y)5.95%
ROA(5y)7.95%
ROE(3y)18.55%
ROE(5y)24.89%
ROIC(3y)9.78%
ROIC(5y)10.35%
ROICexc(3y)10.97%
ROICexc(5y)11.73%
ROICexgc(3y)29.64%
ROICexgc(5y)29.05%
ROCE(3y)16.03%
ROCE(5y)16.96%
ROICexcg growth 3Y-9.69%
ROICexcg growth 5Y2.94%
ROICexc growth 3Y-20.13%
ROICexc growth 5Y-1%
OM growth 3Y-14.93%
OM growth 5Y2.07%
PM growth 3Y-24.31%
PM growth 5Y-2.64%
GM growth 3Y-0.44%
GM growth 5Y3.48%
F-Score8
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.52 | ||
| Debt/FCF | 5.76 | ||
| Debt/EBITDA | 3.05 | ||
| Cap/Depr | 47.34% | ||
| Cap/Sales | 3.41% | ||
| Interest Coverage | 4.1 | ||
| Cash Conversion | 71.11% | ||
| Profit Quality | 163.6% | ||
| Current Ratio | 1.84 | ||
| Quick Ratio | 0.87 | ||
| Altman-Z | 2.04 |
F-Score8
WACC6.06%
ROIC/WACC1.24
Cap/Depr(3y)41.99%
Cap/Depr(5y)70.86%
Cap/Sales(3y)3.57%
Cap/Sales(5y)4.47%
Profit Quality(3y)204.39%
Profit Quality(5y)161.92%
High Growth Momentum
Growth
EPS 1Y (TTM)29.17%
EPS 3Y-18.42%
EPS 5Y8.07%
EPS Q2Q%21.61%
EPS Next Y13.74%
EPS Next 2Y12.47%
EPS Next 3Y11.86%
EPS Next 5Y14.22%
Revenue 1Y (TTM)3.98%
Revenue growth 3Y7.79%
Revenue growth 5Y11%
Sales Q2Q%-2.74%
Revenue Next Year-0.58%
Revenue Next 2Y1.65%
Revenue Next 3Y2.36%
Revenue Next 5Y2.79%
EBIT growth 1Y14.2%
EBIT growth 3Y-8.31%
EBIT growth 5Y13.3%
EBIT Next Year57.91%
EBIT Next 3Y19.98%
EBIT Next 5Y7.57%
FCF growth 1Y-34.18%
FCF growth 3Y-4.81%
FCF growth 5Y24.67%
OCF growth 1Y-28.97%
OCF growth 3Y-7%
OCF growth 5Y14.89%